StockData
Evommune, Inc. logo

Evommune, Inc. (EVMN) stock

EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$8.02−0.60 (-6.96%)

Close on Nov 12, 2026Market cap $291.06MP/E –Yield –

Evommune statistics

62 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Dec 10, 2026 (estimated, after the close)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$291.06M
$280.48M
Enterprise Value
$122.43M
$148.62M
PB Ratio
1.16
2.05
P/TBV Ratio
1.16
2.29

Share statisticsIndustry

Shares Change (QoQ)
0.28%
0.48%
Float
18M
49M
Shares Held by Insiders
51.6%
12.1%
Shares Held by Institutions
95.4%
56.4%

Short sellingIndustry

Short Interest
3M
–
Short Interest Change
-4.14%
-0.76%
Short % of Float
19.3%
9.06%
Short % of Shares Outstanding
9.33%
6.30%
Days to Cover
2.96
5.13

Stock price statisticsIndustry

52-Week High
$33.20
–
52-Week Low
$4.94
–
20-Day Moving Average
$6.23
–
50-Day Moving Average
$7.65
–
200-Day Moving Average
$17.22
–
Average True Range (14)
$0.71
–
Price Change (1 Week)
25.9%
1.51%
Price Change (1 Month)
39.0%
-2.37%
Price Change (3 Months)
-45.3%
-21.1%
Price Change (6 Months)
-64.7%
-22.8%
Price Change (YTD)
-53.2%
-22.6%
Price Change (1 Year)
-58.8%
-21.0%
Average Volume (10 Days)
760,167
–
Average Volume (20 Days)
980,728
–
Average Volume (90 Days)
754,345
–
Relative Volume
1.51
0.80
Relative Strength Index (14)
60.6
44.7
Volatility (1 Year)
120.3%
80.2%

Returns on capitalIndustry

Return on Equity (ROE)
-331.4%
-51.3%
Return on Assets (ROA)
-62.3%
-40.7%
Return on Capital Employed (ROCE)
-47.3%
-38.1%

Financial positionIndustry

Current Ratio
8.52
3.31
Quick Ratio
8.23
2.41

GrowthIndustry

Revenue Growth (YoY)
-100.0%
7.26%

EfficiencyIndustry

Asset Turnover
0.00
0.40
Revenue Per Employee
$0
$429.38K
Profits Per Employee
-$2.36M
-$683.67K
Employee Count
48
75

Income statement (TTM)Industry

Revenue
$0
$66.69M
Operating Income
-$121.89M
-$20.99M
Net Income
-$113.07M
-$21.61M
EBITDA
-$121.29M
-$16.85M

Balance sheetIndustry

Net Cash (Debt)
$168.64M
$16.98M
Net Cash Per Share
$4.65
$0.72
Equity (Book Value)
$251.37M
$52.68M
Book Value Per Share
$6.93
$1.50
Tangible Book Value
$251.37M
$26.74M
Working Capital
$154.08M
$78.52M

Cash flow (TTM)Industry

Operating Cash Flow
-$90.40M
-$12.27M
Capital Expenditures
-$603.00K
-$944.00K
Free Cash Flow
-$91.00M
-$18.20M
FCF Per Share
-$2.51
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-38.8%
-21.0%
FCF Yield
-31.3%
-9.44%

Taxes and interestIndustry

Income Tax
$0
$74.00K

Scores and fair valueIndustry

Altman Z-Score
4.17
0.26
Piotroski F-Score
5
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodEVMNS&P 500DifferenceEVMN per yearS&P 500 per year
1 month+32.6%-2.7%+35.3 pts
3 months-43.2%-1.7%−41.5 pts
Year to date-53.2%+11.9%−65.0 pts
1 year-58.9%+12.0%−70.9 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M EVMN shares were sold short on Oct 30, 2026, down 4.1% from the previous report, or 19.29% of the shares available to trade. At recent volumes it would take 3.0 days to buy them back. Over the last 20 sessions, 49.5% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20263,386,656-4.1%1,145,3853.0
Oct 15, 20263,533,042+22.1%1,031,7253.4
Sep 30, 20262,892,407+0.6%749,5253.9
Sep 15, 20262,876,209-34.1%866,6373.3
Aug 31, 20264,364,904-7.1%375,19611.6
Aug 14, 20264,697,591+4.8%571,9938.2
Jul 31, 20264,481,198+11.5%517,0458.7
Jul 15, 20264,017,562-15.9%1,097,0963.7
Jun 30, 20264,779,126+11.9%1,812,8482.6
Jun 15, 20264,269,495+7.4%451,7289.4
May 29, 20263,975,305+28.3%431,9589.2
May 15, 20263,099,318-4.6%433,3807.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?